Genomic & Biopharma News

ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
ORB Company News, 2019-01-22 23:24:59

Duke to lead PCORI-funded study of COVID-19 prevention in healthcare workers
The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine (HCQ) as a preventive drug for the novel coronavirus.
News Medical Life Sciences, 2020-04-02 01:00:01

Measuring the severity of COVID-19 using a model-based analysis
Researchers have modeled the progression and severity of COVID-19. Their study titled “Estimates of the severity of coronavirus disease 2019: a model-based analysis” was published in the latest issue of The Lancet Infectious Diseases.
News Medical Life Sciences, 2020-04-02 00:36:30

PREDICT receives extension to provide emergency support for COVID-19 outbreak response
PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.
News Medical Life Sciences, 2020-04-02 00:35:19

Healthy Nevada Project participants report on possible exposure and risks of COVID-19
The Healthy Nevada Project, a first-of-its-kind, community-based population health study combining genetic, clinical, environmental and social data, offers free genetic testing to every Nevadan interested in learning more about their health and genetic profile.
News Medical Life Sciences, 2020-04-02 00:27:00

Immunotherapy may benefit mCRPC patients with specific markers of immune activation
Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.
News Medical Life Sciences, 2020-04-02 00:11:57

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

A global, online crowdsourcing challenge launched to accelerate epilepsy research
Novela Neurotech, a medtech company that accelerates neurological discoveries, joins forces with NeuroTechX, an international neurotech community to launch a global, online crowdsourcing challenge with the goal of accelerating epilepsy research.
News Medical Life Sciences, 2020-04-02 00:03:29

Estimating the case fatality ratio for COVID-19
The Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) that causes COVID-19 disease has affected 932,605 individuals and has taken 46,809 lives worldwide. Now, researchers have published a review on the likelihood of survival after SARS-CoV-2 infection. The study titled, “Likelihood of survival of coronavirus disease 2019” is published in the latest issue of The Lancet Infectious Diseases.
News Medical Life Sciences, 2020-04-02 00:01:00

Information overload on COVID-19 leads people to pick out bizarre, unhelpful choices
That the COVID-19 situation has been accompanied by a relentless flood of information is evident from a quick examination of newspaper front pages, top stories on any news channel, or trending topics on Twitter.
News Medical Life Sciences, 2020-04-01 23:58:48

Significant global investment in treating children with cancer could save 11 million lives
A significant, sustained, global investment in treating children with cancer could save 11 million lives and yield a triple return on investment, according to a Lancet Oncology Commission report published by Lancet.
News Medical Life Sciences, 2020-04-01 23:50:19